Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11786523 Composition and method for reducing thrombocytopenia

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
January 23, 2019
Date of Patent
October 17, 2023
Patent Application Number
16964401
Patent Citations
‌
US Patent 7635757 B7-4 Antibodies and uses therefor
‌
US Patent 7674903 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
‌
US Patent 7700615 Cell migration inhibiting compositions and methods and compositions for treating cancer
‌
US Patent 7919497 Analogs of dehydrophenylahistins and their therapeutic use
‌
US Patent 7935704 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
‌
US Patent 7943743 Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
‌
US Patent 7956058 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
‌
US Patent 8008449 Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics
‌
US Patent 8129527 Analogs of dehydrophenylahistins and their therapeutic use
‌
US Patent 8168757 PD-1 binding proteins
•••
Patent Inventor Names
Lan Huang
Ramon Mohanlal
George Kenneth Lloyd
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11786523
Patent Primary Examiner
‌
Jonathan S Lau
CPC Code
‌
A61P 7/02
‌
A61K 31/496

Find more entities like US Patent 11786523 Composition and method for reducing thrombocytopenia

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo